J. Michael Paterson

J. Michael Paterson

Auto-generated profile, based on publicly available information

J. Michael Paterson

ICES, Toronto, Canada

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2014 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
JWJessica Widdifield
Jessica Widdifield
CBClaire Bombardier
Claire Bombardier
SBSasha Bernatsky
Sasha Bernatsky
JPJ Michael Paterson
J Michael Paterson
DGDiane Green
Diane Green
KTKaren Tu
Karen Tu
We have previously validated administrative data algorithms to identify patients with rheumatoid arthritis (RA) using rheumatology clinic records as the reference standard. Here we reassessed the accuracy of the algorithms using primary care records as the reference standard.

28 November 2018 in Arthritis Care & Research
Verified
Journal Article
Closed access
PDF file
JWJessica Widdifield
Jessica Widdifield
JPJ. Michael Paterson
J. Michael Paterson
AHAnjie Huang
Anjie Huang
SBSasha Bernatsky
Sasha Bernatsky

3 November 2020 in Annals of Internal Medicine
Verified
Journal Article
Closed access
ADAristithes G. Doumouras
Aristithes G. Doumouras
DHDennis Hong
Dennis Hong
Yung LeeYung Lee
Yung Lee
JTJean-Eric Tarride
Jean-Eric Tarride
JPJ. Michael Paterson
J. Michael Paterson
MAMehran Anvari
Mehran Anvari
Previous observational studies have found a substantially lower long-term mortality risk associated with bariatric surgery, but selection bias and residual confounding remain a concern. This large ... Visual Association Between Bariatric Surgery and All-Cause Mortality Previous observational studies have found a substantially lower long-term mortality risk associated with bariatric surg... Background: Mortality after bariatric surgery has been previously studied, but cohort selection bias, completeness of follow-up, and collection of confounders have limited the inference of results....

9 May 2024 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
RMRaman Mundi
Raman Mundi
DPDaniel Pincus
Daniel Pincus
ESEmil Schemitsch
Emil Schemitsch
SESeper Ekhtiari
Seper Ekhtiari
JPJ. Michael Paterson
J. Michael Paterson
BRBheeshma Ravi
Bheeshma Ravi
Background: Periprosthetic joint infection (PJI) remains a dreaded and unpredictable complication after total hip arthroplasty (THA). In addition to causing substantial morbidity, PJI may contribute to long-term mortality risk. Our objective was to determine the long-term mortality risk associated with PJI following THA. Methods: This population-based, retrospective cohort study included adult patients (≥18 years old) in Ontario, Canada, who underwent their first primary elective THA for arthritis between April 1, 2002, and March 31, 2021. The primary outcome was death within 10 years after the index THA. Mortality was compared between propensity-score-matched groups (PJI within 1 year after surgery versus no PJI within 1 year after surgery) with use of survival analyses. Patients who died within 1 year after surgery were excluded to avoid immortal time bias. Results: A total of 175,432 patients (95,883 [54.7%] women) with a mean age (and standard deviation) of 67 ± 11.4 years underwent primary THA during the study period. Of these, 868 patients (0.49%) underwent surgery for a PJI of the replaced joint within 1 year after the index procedure. After matching, patients with a PJI within the first year had a significantly higher 10-year mortality rate than their counterparts (11.4% [94 of 827 patients] versus 2.2% [18 of 827 patients]; absolute risk difference, 9.19% [95% confidence interval (CI), 6.81% to 11.6%]; hazard ratio, 5.49 [95% CI, 3.32 to 9.09]). Conclusions: PJI within 1 year after surgery is associated with over a fivefold increased risk of mortality within 10 years. The findings of this study underscore the importance of prioritizing efforts related to the prevention, diagnosis, and treatment of PJIs. Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

1 April 2022 in The Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
JPJ. Denise Power
J. Denise Power
APAnthony V. Perruccio
Anthony V. Perruccio
JPJ. Michael Paterson
J. Michael Paterson
MCMayilee Canizares
Mayilee Canizares
CVChristian Veillette
Christian Veillette
YRY. Raja Rampersaud
Y. Raja Rampersaud
Objective.: To examine the magnitude and costs of ambulatory primary care, specialist physician care, and hospital service use for musculoskeletal disorders (MSDs) in Canada’s largest province, Ontario.Methods.: Administrative health databases were analyzed for fiscal year 2013–2014 for adults aged ≥ 18 years, including data on physician services, emergency department (ED) visits, and hospitalizations. International Classification of Diseases diagnostic codes were used to identify MSD services. A validated algorithm was used to estimate direct medical costs. Person-visit rates and numbers of persons and visits were tabulated by care setting, age, sex, and physician specialty. Data were examined for all MSDs combined, as well as for specific diagnostic groupings.Results.: Overall, 3.1 million adult Ontarians (28.5%) made over 8 million outpatient physician visits associated with MSDs. These included 5.6 million primary care visits. MSDs accounted for 560,000 (12.3%) of all adult ED visits. Total costs for MSD-related care were $1.6 billion, with 12.6% of costs attributed to primary care, 9.2% to specialist care, 8.6% to ED care, 8.5% to day surgery, and 61.2% associated with inpatient hospitalizations. Costs due to arthritis accounted for 40% of total MSD care costs ($639 million). MSD-related imaging costs were $169 million, yielding a total cost estimate of $1.8 billion for MSDs overall.Conclusion.: MSDs place a significant and costly burden on the healthcare system. Health system planning needs to consider the large and escalating demand for care to reduce both the individual and population burden.

6 August 2014 in Implementation Science
Verified
Journal Article
Open access
PDF file
MZMerrick Zwarenstein
Merrick Zwarenstein
SSSusan K Shiller
Susan K Shiller
RCRuth Croxford
Ruth Croxford
JGJeremy Grimshaw
Jeremy Grimshaw
DKDiane Kelsall
Diane Kelsall
JHJanet E Hux
Janet E Hux
Evidence of the effectiveness of printed educational messages in narrowing the gap between guideline recommendations and practice is contradictory. Failure to screen for retinopathy exposes primary care patients with diabetes to risk of eye complications. Screening is initiated by referral from family practitioners but adherence to guidelines is suboptimal. We aimed to evaluate the ability of printed educational messages aimed at family doctors to increase retinal screening of primary care patients with diabetes. Design: Pragmatic 2×3 factorial cluster trial randomized by physician practice, involving 5,048 general practitioners (with 179,833 patients with diabetes). Setting: Ontario family practitioners. Interventions: Reminders (that retinal screening helps prevent diabetes-related vision loss and is covered by provincial health insurance for patients with diabetes) with prompts to encourage screening were mailed to each physician in conjunction with a widely-read professional newsletter. Alternative printed materials formats were an ‘outsert’ (short, directive message stapled to the outside of the newsletter), and/or a two-page, evidence-based article (‘insert’) and a pre-printed sticky note reminder for patients. Main outcome measure: A successful outcome was an eye examination (which includes retinal screening) provided to a patient with diabetes, not screened in the previous 12 months, within 90 days after visiting a family practitioner. Analysis accounted for clustering of doctors within practice groups. No intervention effect was detected (eye exam rates were 31.6% for patients of control physicians, 31.3% for the insert, 32.8% for the outsert, 32.3% for those who received both, and 31.2% for those who received both plus the patient reminder with the largest 95% confidence interval around any effect extending from −1.3% to 1.1%). This large trial conclusively failed to demonstrate any impact of printed educational messages on screening uptake. Despite their low cost, printed educational messages should not be routinely used in attempting to close evidence-practice gaps relating to diabetic retinopathy screening. ISRCTN72772651